Ambry Genetics

12/23/2025

We’re proud to share our latest collaboration with Dana-Farber Cancer Institute. In a case-control study of 488 sarcoma patients and 2,440 matched controls, we found germline pathogenic variants in 26.2% of sarcoma cases vs. 10.5% of controls—a rate exceeding prior estimates of 10–15%. These findings may help lead to evidence-based genetic testing recommendations for sarcoma patients to improve personalized care and familial risk assessment.
https://hubs.ly/Q03YYb3M0

12/23/2025

Connolly Steigerwald, MS, CGC, joins us in the Gene Scene to explore TGFBR2-related Loeys-Dietz syndrome. https://hubs.ly/Q03YY8CM0

12/22/2025

Looking for a digital solution to help more patients get ahead of cancer? The Ambry CARE Program® supports practices in scaling hereditary cancer risk assessment and personalized cancer risk management.
Explore our resources:
• CARE Research for Your Practice – digest of our validation study showing CARE’s accuracy and reliability in identifying patients who qualify for hereditary cancer testing https://hubs.ly/Q03YRCXv0
• HCA Case Study – CARE’s success across a large community health system, standardizing risk assessment and enabling proactive care https://hubs.ly/Q03YRF3b0
• MRA Case Study – CARE’s impact in breast imaging centers, improving workflows and expanding access to advanced screening https://hubs.ly/Q03YRF6W0

12/19/2025

You want the best information for your practice, but it's hard to keep up with the new discoveries and changing guidelines. and we've done the work for you! We share our in these that highlight what you need to know:
https://hubs.ly/Q03YD4Jt0

12/18/2025

Join us for the third annual research round-up!
Look back at 2025 research with a fast, focused review of the top ten most impactful genetics papers of the year and what they mean for real-world clinical decision making. Ambry’s experts will break down key findings, highlight clinical implications across oncology and rare disease, and share practical guidance you can apply to your practice.
Register today! https://hubs.ly/Q03YD32x0

12/18/2025

We’re thrilled to highlight Adela Rodríguez-Hernández, MD, in our Making Waves series, dedicated to spotlighting the extraordinary work of healthcare providers and researchers who are creating ripple effects of impact in their communities.
As a research fellow in the Cancer Genetics and Prevention group at Dana-Farber Cancer Institute—trained as a medical oncologist in Spain and specializing in hereditary cancer and translational genomics—Dr. Rodríguez-Hernández is often asked how to counsel patients who carry rare pathogenic variants, particularly when evidence is limited or outdated. In this blog, she explores results from a newly published study in Gynecologic Oncology, where a decade of clinical testing data was analyzed to better characterize cancer patterns among individuals with SMARCA4 gPVs, in order to help address long-standing gaps in counseling, surveillance, and prevention.
The waves these extraordinary scientists make extend far beyond a single patient—they touch families, futures, and generations to come.

🌊 Dive into the research: https://hubs.ly/Q03YD35t0

12/17/2025

Hereditary cancer testing can make a big impact—not just for patients, but for their families too!

At Mercy’s Center for Precision Medicine in St. Louis, one patient’s journey shows how the Ambry CARE Program® identified him as eligible for hereditary cancer testing. That testing provided important information for his care and ultimately helped save his daughter’s life.
This story underscores the importance of high-risk patient identification and the power of strong partnerships that put patients at the center.
Check out the full story here: https://hubs.ly/Q03YtjZp0

On Demand Arts, Culture & Education Programming

12/16/2025

Ambry is the proud recipient of three new Comparably awards. In addition to Best Company Compensation and Best Company Culture, we want to give a special shout out to Tom Schoenherr who was recognized in the Best CEOs category.

12/16/2025

Haaniya Mallick, MS, CGC, joins us in the Gene Scene to explore KCNQ1-related long QT Syndrome (LQTS), including autosomal dominant LQTS1, autosomal-recessive LQTS1 (AR-LQTS), and Jervell and Lange-Nielsen syndrome (JLNS). Dive deeper:
https://hubs.ly/Q03YkpCC0

12/15/2025

We want to wish everyone a merry and bright holiday season, filled with warmth, light, and love.

12/15/2025

Are you part of the ? We are proud of our , and we want to make sure you have the best information for your practice.
Check out our Provider Resources, including Research for Your Practice, which highlight significant research findings that are relevant for you.
https://hubs.ly/Q03Y8Jyd0

12/12/2025

Are you part of the ? We are proud of our , and we know the path forward is always smoother with . We want to highlight some resources we have available for you!
Looking for continuing education that also awards CEUs? Check out our EducateNext webinars! https://hubs.ly/Q03X_LX-0